LMRI · XBRL financial data
Lumexa Imaging Holdings financial statements, every quarter
The same tables from 2 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal quarters
| In millions of dollars | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|
| Revenue from contracts with customers | 253 | 264 |
| General and administrative | 20 | 24 |
| Total operating expenses | 248 | 260 |
| Operating income (loss) | 19 | 23 |
| Interest expense | 16 | 16 |
| Other income (expense) | — | (17) |
| Income tax expense (benefit) | 1 | 3 |
| Net income (loss) | 2 | 3 |
| Earnings per share, basic USD per share | 0.02 | 0.03 |
| Earnings per share, diluted USD per share | 0.02 | 0.03 |
| Weighted average shares, basic millions of shares | 96 | 96 |
| Weighted average shares, diluted millions of shares | 96 | 96 |
Balance sheet
CSVFiscal quarters
| In millions of dollars | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|
| Cash and cash equivalents | 51 | 70 |
| Total current assets | 222 | 256 |
| Property and equipment, net | 150 | 156 |
| Right-of-use asset | 76 | 77 |
| Goodwill | 808 | 808 |
| Total assets | 1,763 | 1,809 |
| Accounts payable | 37 | 27 |
| Current portion of long-term debt | 13 | 14 |
| Total current liabilities | 158 | 178 |
| Long-term debt | 817 | 820 |
| Lease liability, non-current | 71 | 72 |
| Total liabilities | 1,164 | 1,194 |
| Accumulated deficit | (629) | (627) |
| Total stockholders' equity | 600 | 615 |
| Total liabilities and equity | 1,763 | 1,809 |
| Common shares outstanding (cover page) millions of shares | 96 | 96 |
Cash flows
CSVFiscal quarters
| In millions of dollars | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|
| Net income (loss) | 2 | 3 |
| Stock-based compensation | 12 | 13* |
| Net cash from operating activities | 3 | 33* |
| Purchases of property and equipment | 5 | 10* |
| Net cash from investing activities | (5) | (14)* |
| Proceeds from long-term debt | 1 | 8* |
| Repayments of long-term debt | 3 | 5* |
| Net cash from financing activities | (5) | (1)* |
| Net change in cash | (8) | 18* |
Compare with peers
SIC 8071 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 8071 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Lumexa Imaging Holdings | 70 | 264 | 33* | 96.1M | — | 10-QJun 30, 2026 |
| Caris Life Sciences | not reported | 264 | 28* | 282.6M | — | 10-QJun 30, 2026 |
| Guardant Health | 1,053 | 335 | (58)* | 134.2M | 18.2 quarters | 10-QJun 30, 2026 |
| Veracyte | 300 | 150 | 46* | 80.4M | — | 10-QJun 30, 2026 |
| CareDx | 250 | 139 | 13* | 52.5M | — | 10-QSep 30, 2026 |
| RadNet | 726 | 623 | 94* | 78.7M | — | 10-QJun 30, 2026 |
| BillionToOne | 549 | 109 | 9.1* | not reported | — | 10-QJun 30, 2026 |
| Castle Biosciences | 62 | 104 | 15* | 30.5M | — | 10-QJun 30, 2026 |
| Fortrea Holdings | 221 | 692 | 61* | 96.5M | — | 10-QSep 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.